Are We Any Closer to Combating Ebola Infections?

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 2010 Jun 1

PMID 20511001

Citations 6

Authors

Heinz Feldmann

Affiliations

Soon will be listed here.

Citing Articles

Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques.

Johnson D, Brasel T, Massey S, Smith J, Garron T, Wallace S J Virol. 2023; 97(5):e0188822.

PMID: 36975793 PMC: 10231233. DOI: 10.1128/jvi.01888-22.

Molecular pathogenesis of viral hemorrhagic fever.

Basler C Semin Immunopathol. 2017; 39(5):551-561.

PMID: 28555386 PMC: 6436832. DOI: 10.1007/s00281-017-0637-x.

Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E Eur J Clin Microbiol Infect Dis. 2016; 35(8):1247-58.

PMID: 27234593 PMC: 7088173. DOI: 10.1007/s10096-016-2657-1.

Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.

Matua G, Wal D, Locsin R Braz J Infect Dis. 2015; 19(3):308-13.

PMID: 25892315 PMC: 9425420. DOI: 10.1016/j.bjid.2015.02.004.

Controlling Ebola: what we can learn from China's 1911 battle against the pneumonic plague in Manchuria.

Liu H, Jiao M, Zhao S, Xing K, Li Y, Ning N Int J Infect Dis. 2015; 33:222-6.

PMID: 25722280 PMC: 7110523. DOI: 10.1016/j.ijid.2015.02.013.

References

Feldmann H, Jones S, Daddario-DiCaprio K, Geisbert J, Stroher U, Grolla A . Effective post-exposure treatment of Ebola infection. PLoS Pathog. 2007; 3(1):e2. PMC: 1779298. DOI: 10.1371/journal.ppat.0030002. View

Tuffs A . Experimental vaccine may have saved Hamburg scientist from Ebola fever. BMJ. 2009; 338:b1223. DOI: 10.1136/bmj.b1223. View

Geisbert T, Pushko P, Anderson K, Smith J, Davis K, Jahrling P . Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis. 2002; 8(5):503-7. PMC: 3369765. DOI: 10.3201/eid0805.010284. View

Geisbert T, Hensley L, Jahrling P, Larsen T, Geisbert J, Paragas J . Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet. 2003; 362(9400):1953-8. DOI: 10.1016/S0140-6736(03)15012-X. View

Groseth A, Feldmann H, Strong J . The ecology of Ebola virus. Trends Microbiol. 2007; 15(9):408-16. DOI: 10.1016/j.tim.2007.08.001. View

Bray M, Paragas J . Experimental therapy of filovirus infections. Antiviral Res. 2002; 54(1):1-17. DOI: 10.1016/s0166-3542(02)00005-0. View

Geisbert T, Lee A, Robbins M, Geisbert J, Honko A, Sood V . Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010; 375(9729):1896-905. PMC: 7138079. DOI: 10.1016/S0140-6736(10)60357-1. View

Geisbert T, Hensley L, Kagan E, Yu E, Geisbert J, Daddario-DiCaprio K . Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006; 193(12):1650-7. PMC: 7110204. DOI: 10.1086/504267. View

Feldmann H, Jones S, Schnittler H, Geisbert T . Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs. 2005; 6(8):823-30. View

10.

Enterlein S, Warfield K, Swenson D, Stein D, Smith J, Gamble C . VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother. 2006; 50(3):984-93. PMC: 1426423. DOI: 10.1128/AAC.50.3.984-993.2006. View

11.

Bente D, Gren J, Strong J, Feldmann H . Disease modeling for Ebola and Marburg viruses. Dis Model Mech. 2009; 2(1-2):12-7. PMC: 2615158. DOI: 10.1242/dmm.000471. View

12.

Warfield K, Swenson D, Olinger G, Nichols D, Pratt W, Blouch R . Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2006; 2(1):e1. PMC: 1326218. DOI: 10.1371/journal.ppat.0020001. View

13.

Hensley L, Stevens E, Yan S, Geisbert J, Macias W, Larsen T . Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis. 2007; 196 Suppl 2:S390-9. DOI: 10.1086/520598. View